Ard Tijsterman
Ard has wide experience in project and organization consulting in the biopharmaceutical arena. He is an entrepreneur and business developer with his roots in biopharmaceutical production, EU/US compliance, validation, process development and drug development (RA, CMC, non-clinical & early stage clinical). Co-founder and co-owner of a number of companies: Xendo, Tarpon Biosystems and BiosanaPharma. As the CEO he has the overall responsibility for the company’s activities and strategy.
Jaap den Engelsman
Jaap den Engelsman is a highly experienced CFO with a track record at a diversity of internationally operating companies that are active in the food and biotechnology field. A number of these companies are: Cavitus, DSM Food Specialties and DSM Biologics. Jaap is co-founder of BiosanaPharma. In his role, Jaap provides continuous insight in and strategic advice on the financial options and position of the company.
Menne Zaalberg
Menne Zaalberg has 30 years of experience in the biotechnology and pharmaceutical industry which includes leading the team with experts and leading the operations of the Process Division within ProPharma Group. As a project manager Menne was responsible for many projects for internationally located companies. These projects include new and revamp biopharmaceutical GMP production suites including (continuous) disposable biomanufacturing, clean utilities and equipment. Prior to that, Menne worked at Applikon Biotechnology as a project manager. Menne is responsible for operations and ICT.
Maarten Pennings
Maarten Pennings has over 20 years of experience in the development of biopharmaceuticals. He spent 12 years at ProPharma as a consultant process development, worked in projects on antibiotics, antibodies and viral vaccines. He has also been working on the development of continuous manufacturing in biopharma since 1999 and is co-inventor of the BioSMB and is in charge of process development and manufacturing for BiosanaPharma since more than six years. Maarten is responsible for the 3C process development and further maturation of the platform into commercial scale.
Core Values
Honed Expertise
A core, non-negotiable value is our constant pursuit of expertise. Continuously growing and evolving as we progress our technologies and products.
Reliable
Trust is built over time, but it also must be maintained and nurtured. That is why our management and operations prioritise reliability in every interaction.
Challenging the limits of biologics manufacturing
Innovation requires persistence and curiosity, we seek to constantly evolve approaches in biologics manufacturing by challenging the limits that stand in the way of progress.
Working for a better world
We recognize that the changes we can make in development and biomanufacturing of biologics have the potential to create lasting and meaningful global change. This belief fuels our decisions and informs our approach.
Board of Directors (BoD)
Bert Tjeenk Willink
Worked for Boehringer Ingelheim for 25 years, from 2008 to 2012 as Board member. Since then he acts as interim CEO and Board member for various (bio)pharma companies, among which Stada AG, which he sold to Private Equity in 2017.
Ard Tijsterman
CEO at BiosanaPharma.
Jan Karel Mak
Fulfilled leadership roles in engineering firms in the Netherlands and served as management consultant. Currently coach, supervisor and investor in various technically oriented companies.
Jaap den Engelsman
CFO at BiosanaPharma.
Scientific Advisory Board
Professor Stephen Mahler is a Senior Group Leader at the Australian Institute for Bioengineering and Nanotechnology and Director of the Australian Research Council Training Centre for Biopharmaceutical Innovation (CBI), University of Queensland.
Ben Rademaker has over 40 years of experience in drug development and drug formulation. He worked in academia and industry and is the founder and co-owner of InProPharma BV.
Jaap is CEO of PureIMS, a company specialized in innovative inhaled therapies. Before that he held executive and research management roles in R&D institutions and commercial research and manufacturing corporations (Biosanapharma, Xendo, TNO, PRA/ICON, DSM).